Advaxis' PIPE Round

Advaxis raised a round of funding on March 09, 2006. Investors include Yorkville Advisors.

Advaxis, Inc. is a biotechnology company that uses a bioengineered bacterium, Listeria monocytogenes to activate the immune system to treat cancer, infectious disease or allergic syndromes.…

Articles about Advaxis' PIPE Round: